Pr ecis: An E3 ubiquitin ligase that targets the BRCA1 breast tumor suppressor for degradation also participates in DNA replication, possibly playing a role in breast carcinogenesis through this mechanism. 
Pr ecis: Results of this clinical trial confirm anticipations that an exciting new class of PARP inhibitors developed for cancer treatment can indeed modulate the capacity to repair topoisomerase I-mediated DNA damage in humans, as predicted by preclinical studies. Pr ecis: Genome wide association studies used to compare the incidence of spontaneous lung adenoma in 28 strains of mice suggest major differences in males and females, with potential implications for understanding human susceptibilities to lung cancer. 
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